Breakthrough fertility method may keep estrogen low during cancer treatment

NCT ID NCT03947151

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a new ovarian stimulation protocol using degarelix (a drug typically used for prostate cancer) to help breast cancer patients preserve their fertility before chemotherapy. The goal was to keep estrogen levels low while still collecting enough eggs for freezing. The study included 8 women aged 18-40 with invasive ductal breast cancer who needed chemotherapy. Researchers measured how many follicles (egg sacs) developed and whether estrogen stayed at safe levels.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INVASIVE DUCTAL BREAST CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Hôpital Antoine Béclère

    Clamart, 92140, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.